Black soy peptide supplementation improves glucose control in subjects with prediabetes and newly diagnosed type 2 diabetes mellitus.

Jung Hyun Kwak, Jong Ho Lee, Chang Won Ahn, Soo Hyun Park, Sun Taek Shim, Yong Duk Song, Eun Narae Han, K. H. Lee, Jey Sook Chae

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The present study aimed to determine the effect of black soy peptide supplementation on glucose control in subjects with prediabetes (impaired fasting glucose or impaired glucose tolerance) and newly diagnosed type 2 diabetes mellitus (DM). In this double-blind, placebo-controlled study, subjects with prediabetes and type 2 DM were randomly assigned to the placebo control group or the black soy peptide intervention group. We determined fasting serum concentrations of glucose, hemoglobin A1c, insulin, and free fatty acids, performed a 2-hour postload glucose (2-hour PG) test, and compared serum lipid profiles before and after the 12-week supplementation. In particular, subjects with fasting glucose ≥ 110 mg/dL who consumed black soy peptides tended to have lower fasting glucose levels (two-tailed test, P =.098; one-tailed test, P =.049) and had a significant reduction in 2-hour PG level (two-tailed P =.012, one-tailed P =.006), compared with baseline levels. The changes in 2-hour PG levels were also statistically significant in the intervention group (-41.25 ± 13.67 mg/dL) compared with the placebo group (12.42 ± 9.80 mg/dL; two-tailed P =.015, one-tailed P =.008). In contrast, hemoglobin A1c levels were not significantly improved by the dietary intervention. In conclusion, black soy peptide supplementation may be beneficial for controlling fasting blood glucose levels and 2-hour PG levels.

Original languageEnglish
Pages (from-to)1307-1312
Number of pages6
JournalJournal of medicinal food
Volume13
Issue number6
DOIs
Publication statusPublished - 2010 Jan 1

Fingerprint

Prediabetic State
Type 2 Diabetes Mellitus
Glucose
Peptides
Fasting
Placebos
Hemoglobins
Glucose Intolerance
Serum
Nonesterified Fatty Acids
Blood Glucose
Insulin
Lipids
Control Groups

All Science Journal Classification (ASJC) codes

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

Kwak, Jung Hyun ; Lee, Jong Ho ; Ahn, Chang Won ; Park, Soo Hyun ; Shim, Sun Taek ; Song, Yong Duk ; Han, Eun Narae ; Lee, K. H. ; Chae, Jey Sook. / Black soy peptide supplementation improves glucose control in subjects with prediabetes and newly diagnosed type 2 diabetes mellitus. In: Journal of medicinal food. 2010 ; Vol. 13, No. 6. pp. 1307-1312.
@article{9493bba8beff4f25a22d301dba6e211e,
title = "Black soy peptide supplementation improves glucose control in subjects with prediabetes and newly diagnosed type 2 diabetes mellitus.",
abstract = "The present study aimed to determine the effect of black soy peptide supplementation on glucose control in subjects with prediabetes (impaired fasting glucose or impaired glucose tolerance) and newly diagnosed type 2 diabetes mellitus (DM). In this double-blind, placebo-controlled study, subjects with prediabetes and type 2 DM were randomly assigned to the placebo control group or the black soy peptide intervention group. We determined fasting serum concentrations of glucose, hemoglobin A1c, insulin, and free fatty acids, performed a 2-hour postload glucose (2-hour PG) test, and compared serum lipid profiles before and after the 12-week supplementation. In particular, subjects with fasting glucose ≥ 110 mg/dL who consumed black soy peptides tended to have lower fasting glucose levels (two-tailed test, P =.098; one-tailed test, P =.049) and had a significant reduction in 2-hour PG level (two-tailed P =.012, one-tailed P =.006), compared with baseline levels. The changes in 2-hour PG levels were also statistically significant in the intervention group (-41.25 ± 13.67 mg/dL) compared with the placebo group (12.42 ± 9.80 mg/dL; two-tailed P =.015, one-tailed P =.008). In contrast, hemoglobin A1c levels were not significantly improved by the dietary intervention. In conclusion, black soy peptide supplementation may be beneficial for controlling fasting blood glucose levels and 2-hour PG levels.",
author = "Kwak, {Jung Hyun} and Lee, {Jong Ho} and Ahn, {Chang Won} and Park, {Soo Hyun} and Shim, {Sun Taek} and Song, {Yong Duk} and Han, {Eun Narae} and Lee, {K. H.} and Chae, {Jey Sook}",
year = "2010",
month = "1",
day = "1",
doi = "10.1089/jmf.2010.1075",
language = "English",
volume = "13",
pages = "1307--1312",
journal = "Journal of Medicinal Food",
issn = "1096-620X",
publisher = "Mary Ann Liebert Inc.",
number = "6",

}

Black soy peptide supplementation improves glucose control in subjects with prediabetes and newly diagnosed type 2 diabetes mellitus. / Kwak, Jung Hyun; Lee, Jong Ho; Ahn, Chang Won; Park, Soo Hyun; Shim, Sun Taek; Song, Yong Duk; Han, Eun Narae; Lee, K. H.; Chae, Jey Sook.

In: Journal of medicinal food, Vol. 13, No. 6, 01.01.2010, p. 1307-1312.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Black soy peptide supplementation improves glucose control in subjects with prediabetes and newly diagnosed type 2 diabetes mellitus.

AU - Kwak, Jung Hyun

AU - Lee, Jong Ho

AU - Ahn, Chang Won

AU - Park, Soo Hyun

AU - Shim, Sun Taek

AU - Song, Yong Duk

AU - Han, Eun Narae

AU - Lee, K. H.

AU - Chae, Jey Sook

PY - 2010/1/1

Y1 - 2010/1/1

N2 - The present study aimed to determine the effect of black soy peptide supplementation on glucose control in subjects with prediabetes (impaired fasting glucose or impaired glucose tolerance) and newly diagnosed type 2 diabetes mellitus (DM). In this double-blind, placebo-controlled study, subjects with prediabetes and type 2 DM were randomly assigned to the placebo control group or the black soy peptide intervention group. We determined fasting serum concentrations of glucose, hemoglobin A1c, insulin, and free fatty acids, performed a 2-hour postload glucose (2-hour PG) test, and compared serum lipid profiles before and after the 12-week supplementation. In particular, subjects with fasting glucose ≥ 110 mg/dL who consumed black soy peptides tended to have lower fasting glucose levels (two-tailed test, P =.098; one-tailed test, P =.049) and had a significant reduction in 2-hour PG level (two-tailed P =.012, one-tailed P =.006), compared with baseline levels. The changes in 2-hour PG levels were also statistically significant in the intervention group (-41.25 ± 13.67 mg/dL) compared with the placebo group (12.42 ± 9.80 mg/dL; two-tailed P =.015, one-tailed P =.008). In contrast, hemoglobin A1c levels were not significantly improved by the dietary intervention. In conclusion, black soy peptide supplementation may be beneficial for controlling fasting blood glucose levels and 2-hour PG levels.

AB - The present study aimed to determine the effect of black soy peptide supplementation on glucose control in subjects with prediabetes (impaired fasting glucose or impaired glucose tolerance) and newly diagnosed type 2 diabetes mellitus (DM). In this double-blind, placebo-controlled study, subjects with prediabetes and type 2 DM were randomly assigned to the placebo control group or the black soy peptide intervention group. We determined fasting serum concentrations of glucose, hemoglobin A1c, insulin, and free fatty acids, performed a 2-hour postload glucose (2-hour PG) test, and compared serum lipid profiles before and after the 12-week supplementation. In particular, subjects with fasting glucose ≥ 110 mg/dL who consumed black soy peptides tended to have lower fasting glucose levels (two-tailed test, P =.098; one-tailed test, P =.049) and had a significant reduction in 2-hour PG level (two-tailed P =.012, one-tailed P =.006), compared with baseline levels. The changes in 2-hour PG levels were also statistically significant in the intervention group (-41.25 ± 13.67 mg/dL) compared with the placebo group (12.42 ± 9.80 mg/dL; two-tailed P =.015, one-tailed P =.008). In contrast, hemoglobin A1c levels were not significantly improved by the dietary intervention. In conclusion, black soy peptide supplementation may be beneficial for controlling fasting blood glucose levels and 2-hour PG levels.

UR - http://www.scopus.com/inward/record.url?scp=79953038841&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953038841&partnerID=8YFLogxK

U2 - 10.1089/jmf.2010.1075

DO - 10.1089/jmf.2010.1075

M3 - Article

VL - 13

SP - 1307

EP - 1312

JO - Journal of Medicinal Food

JF - Journal of Medicinal Food

SN - 1096-620X

IS - 6

ER -